|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Mr. Christian Wichert||Chief Executive Officer||599,9k||N/D||1974|
|Mr. Carsten Daweritz||Chief Financial Officer||N/D||N/D||1973|
|Mr. Gerhard Lobmaier||Chief Operations Officer||N/D||N/D||1969|
|Thomas Schneckenburger C.F.A., Ph.D.||Head of Investor & Corporate Relations||N/D||N/D||N/D|
|Philipp Frech||General Counsel & Secretary of the Board||N/D||N/D||N/D|
|Ms. Astrid Schafer||Head of Research & Development||N/D||N/D||1973|
|Ms. Anne De Vos||Chief Commercial Officer||N/D||N/D||1964|
|Dr. Luc Gruner||Executive Officer||N/D||N/D||1952|
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
L'ISS Governance QualityScore di Evolva Holding SA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.